Arcellx, Inc. (ACLX)
72.18
+3.24
(+4.69%)
USD |
NASDAQ |
Jan 20, 16:00
72.05
-0.12
(-0.17%)
After-Hours: 20:00
Arcellx Market Cap: 4.173B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 154.23B |
| Johnson & Johnson | 525.64B |
| Amicus Therapeutics, Inc. | 4.417B |
| Relmada Therapeutics, Inc. | 289.67M |
| Invivyd, Inc. | 523.36M |
Market Cap Related Metrics
| PS Ratio | 111.77 |
| PEG Ratio | -0.0433 |
| Price to Book Value | 9.468 |
| Price | 72.18 |
| Earnings Yield | -5.43% |
| PEGY Ratio | -0.0433 |